C57BL/6JCya-Fam72aem1/Cya
Common Name
Fam72a-KO
Product ID
S-KO-00630
Backgroud
C57BL/6JCya
Strain ID
KOCMP-108900-Fam72a-B6J-VA
When using this mouse strain in a publication, please cite “Fam72a-KO Mouse (Catalog S-KO-00630) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Fam72a-KO
Strain ID
KOCMP-108900-Fam72a-B6J-VA
Gene Name
Product ID
S-KO-00630
Gene Alias
P17, 2700049P18Rik
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 1
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000068613
NCBI RefSeq
NM_175382
Target Region
Exon 2~3
Size of Effective Region
~4.3 kb
Overview of Gene Research
Fam72a, a poorly characterized yet evolutionarily conserved gene across multicellular organisms, plays multifaceted roles [2]. It is a cell-cycle-regulated gene, transcriptionally regulated by FoxM1 and post-transcriptionally by APC/C. Functionally, it binds to tubulin and subunits of PP2A-B56, modulating tubulin and Mcl1 phosphorylation, thus influencing cell-cycle progression, apoptosis signaling, and chemotherapy responses [2]. In the context of antibody maturation, Fam72a is a key determinant for the error-prone processing of deoxyuracils [1,3].
Fam72a-deficient CH12F3-2 B cells and primary B cells from Fam72a-/-mice exhibit reduced class-switch recombination and somatic hypermutation frequencies at immunoglobulin and Bcl6 genes, along with reduced genome-wide deoxyuracils [1]. The somatic hypermutation spectrum in B cells from Fam72a-/-mice is opposite to that in UNG2-deficient mice, suggesting hyperactive UNG2 in FAM72A-deficient cells [1]. FAM72A binds to UNG2, reducing UNG2 protein levels in the G1 phase, causing U·G mispairs to persist into S phase and leading to error-prone processing by mismatch repair [1]. Also, in multiple myeloma, overexpression of FAM72A in U266 cells promotes cell proliferation, inhibits apoptosis, and reduces sensitivity to bortezomib by regulating the POU2F2/FAM72A/p53 signaling pathway [4].
In summary, Fam72a is crucial for cell-cycle regulation, apoptosis, and antibody maturation. The study of Fam72a-deficient mouse models has revealed its role in antibody-related mutagenic repair and its potential significance in cancer-related processes such as in multiple myeloma, highlighting its importance as a potential therapeutic target in these disease areas [1,2,4].
References:
1. Feng, Yuqing, Li, Conglei, Stewart, Jessica A, Bhagwat, Ashok S, Martin, Alberto. 2021. FAM72A antagonizes UNG2 to promote mutagenic repair during antibody maturation. In Nature, 600, 324-328. doi:10.1038/s41586-021-04144-4. https://pubmed.ncbi.nlm.nih.gov/34819670/
2. Fu, Yuan, Jia, Xiaofan, Yuan, Jinwei, Zhou, Jun, Wang, Ting. 2023. Fam72a functions as a cell-cycle-controlled gene during proliferation and antagonizes apoptosis through reprogramming PP2A substrates. In Developmental cell, 58, 398-415.e7. doi:10.1016/j.devcel.2023.02.006. https://pubmed.ncbi.nlm.nih.gov/36868233/
3. Rogier, Mélanie, Moritz, Jacques, Robert, Isabelle, Deriano, Ludovic, Reina-San-Martin, Bernardo. 2021. Fam72a enforces error-prone DNA repair during antibody diversification. In Nature, 600, 329-333. doi:10.1038/s41586-021-04093-y. https://pubmed.ncbi.nlm.nih.gov/34819671/
4. Gao, Wenyu, Ma, Yanping. . Expression and Function of FAM72A Gene in Multiple MyelomaFAM72A. In Current pharmaceutical biotechnology, 26, 455-464. doi:10.2174/0113892010311258240729080309. https://pubmed.ncbi.nlm.nih.gov/39129160/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
